399 Shares in Axon Enterprise, Inc (NASDAQ:AXON) Acquired by Optivise Advisory Services LLC

Optivise Advisory Services LLC acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 399 shares of the biotechnology company's stock, valued at approximately $210,000.

Several other large investors have also made changes to their positions in the business. Prosperity Wealth Management Inc. lifted its position in shares of Axon Enterprise by 6.1% in the first quarter. Prosperity Wealth Management Inc. now owns 867 shares of the biotechnology company's stock valued at $456,000 after acquiring an additional 50 shares in the last quarter. Strategic Advisors LLC increased its holdings in shares of Axon Enterprise by 372.1% in the first quarter. Strategic Advisors LLC now owns 2,016 shares of the biotechnology company's stock worth $1,060,000 after purchasing an additional 1,589 shares during the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI increased its holdings in shares of Axon Enterprise by 9.6% in the first quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 18,971 shares of the biotechnology company's stock worth $9,978,000 after purchasing an additional 1,669 shares during the last quarter. Vivid Wealth Management LLC increased its holdings in shares of Axon Enterprise by 6.4% in the first quarter. Vivid Wealth Management LLC now owns 4,145 shares of the biotechnology company's stock worth $2,180,000 after purchasing an additional 250 shares during the last quarter. Finally, Great Lakes Retirement Inc. increased its holdings in shares of Axon Enterprise by 0.7% in the first quarter. Great Lakes Retirement Inc. now owns 3,841 shares of the biotechnology company's stock worth $2,020,000 after purchasing an additional 27 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, CAO Jennifer H. Mak sold 75 shares of the stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $771.81, for a total value of $57,885.75. Following the transaction, the chief accounting officer now owns 15,240 shares of the company's stock, valued at $11,762,384.40. This represents a 0.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 9,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $683.31, for a total value of $6,149,790.00. Following the completion of the transaction, the president now directly owns 308,714 shares in the company, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 44,642 shares of company stock worth $30,500,428 in the last 90 days. 4.40% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on AXON. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Barclays lifted their target price on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Bank of America boosted their price objective on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. Finally, Needham & Company LLC boosted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Trading Up 0.8%

Shares of AXON traded up $6.53 during mid-day trading on Friday, reaching $777.32. 1,181,999 shares of the company's stock traded hands, compared to its average volume of 476,402. The stock has a market cap of $60.51 billion, a P/E ratio of 187.76, a P/E/G ratio of 88.73 and a beta of 1.29. The stock's 50-day moving average is $692.15 and its two-hundred day moving average is $626.13. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $806.64. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The company's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.15 earnings per share. Research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.